All news articles for April 2022

Minafin Group: “For hexane we are the rats”

Minafin Group: “For hexane we are the rats”

By Lynda Searby

EFSA has issued a positive opinion about the safety of methyloxolane in food processing, bringing the industry closer to the prospect of a bio-based alternative to petroleum extraction solvents.

©iStock Dmitrii Kotin

Can psychobiotics soothe a simmering post-happy world?

By Will Chu

Gut-brain axis (GBX)-focused probiotic supplements have tripled to 200+ offerings since 2019, as promising science and self-medicating consumers seek solutions to a global mental health crisis afflicting a billion people, according to Lumina Intelligence.

© Handatko / Getty Images

CV Sciences reports 18% revenue drop for ‘challenging’ 2021

By Stephen Daniells

San Diego-based CV Sciences, one of the bell-weather companies in the hemp and CBD space, has reported a decline in revenues for the past financial year, but new initiatives have positioned the company for long-term growth, says its CEO.

BLIS K12 is part of a portfolio of clinically documented bacterial strains for supporting our natural immune defense and preventing infections of the mouth and throat.   Image © Jan-Otto / Getty Images

News in brief

Probi announced 1st production batches of dairy-free BLIS K12

By Stephen Daniells

Probiotic player Probi has completed the first commercial production batches of a dairy-free BLIS K12 at its US manufacturing site, with the new BLIS strains available shortly to customers around the world.

© Getty Images

UK’s FSA unveils list of permitted CBD products

By Kavitha Sivasubramaniam

The UK’s Food Standards Agency (FSA) has released a list of cannabinoid (CBD) products which can be sold to consumers, becoming the first country globally to regulate the market for orally consumed, safe legal cannabis extracts.

Follow us

Products

View more

Webinars